ABN Cleanroom Technology, founded in 1996, is a specialist in the design, construction, commissioning, and maintenance of cleanrooms for a wide range of industries, including healthcare, biotechnology, pharmaceuticals, microelectronics, automotive, and food processing.

As an innovator in Industry 4.0-connected cleanroom solutions, ABN focuses on making advanced cleanroom technology more accessible and cost-effective. Rather than focusing solely on the initial investment, the company takes a Total Cost of Ownership (TCO) approach, considering energy efficiency, reliability, operational performance, and long-term maintenance.

ABN’s pre-engineered cleanroom solutions help accelerate project delivery while improving energy efficiency and reliability, enabling customers to achieve high-quality, future-ready cleanroom environments with optimized lifecycle costs.

Click here for more information

Anacura is an independent healthcare and pharmaceutical development knowledge center supporting innovation across medical diagnostics, drug development, and the life sciences. Through its specialized entities – Labo Nuytinck, Anabiotec, OHMX.bio, and Anacura Discovery Studio — it combines expertise in analytical sciences, omics, cellular biology, and bioinformatics.

Anacura supports the development of small molecules, biologics, and cell and gene therapies throughout the development lifecycle. Its advanced omics and bioinformatics capabilities provide deeper insights into disease mechanisms and patient-specific biology, while its translational research expertise helps turn these insights into therapeutic applications. By connecting biological data with drug development, Anacura contributes to more targeted therapies and the advancement of personalized medicine.

Click here for more information

anicells, an accelerator platform for cell therapy products, aims to facilitate the go-to-patient process of cell therapy products.

Today, cell therapy is at the cutting edge of development. The use of living cells from a patient or healthy donors as a medicine has the potential to improve the lives of patients suffering from serious conditions where currently limited or no therapeutic options exist. Yet, some challenges in the development of these cell products slow down the final availability of safe, efficient and affordable treatments for all patients.

To facilitate the early clinical trials and to overcome the challenges observed in the go-to-patient process, anicells is created from a joint initiative of the University of Antwerp, the University Hospital Antwerp and POM, supported by both the Flemish and the European governments. anicells offers support services for clinical cell therapy development and access to GMP-compliant infrastructure for manufacturing cell therapy products.

Click here for more information

BioNotus is a European bioanalytical start-up providing state-of-the-art services to clients involved in clinical and non-clinical research, drug development, and the life sciences. Since its establishment in 2017, the company has developed expertise in the bioanalysis of drugs and their metabolites in biological fluids such as blood, plasma, and urine. Samples can be provided by hospitals and medical specialists, enabling BioNotus to support research and clinical applications with high-quality analytical data.

A key strength of BioNotus is its ability to deliver rapid turnaround times while maintaining the highest quality standards and complying with relevant regulatory guidelines. In addition to analytical services, BioNotus can, upon request from medical specialists, provide recommendations on potential adjustments to dosage regimens based on analytical results. By combining reliable bioanalysis with fast, patient-relevant insights, BioNotus supports more informed decision-making in drug development and clinical practice, contributing to more personalized and effective treatment approaches.

Click here for more information

BioVIA is the health innovation cluster for Flanders, Belgium, bringing together human and planetary health in one vibrant ecosystem. As an industry-driven membership organization, it connects more than 450 companies, research institutions, universities, hospitals, service providers, investors, and government bodies across medical biotechnology, medtech, digital health, agtech, and industrial biotechnology.

By connecting stakeholders across these sectors, BioVIA fosters collaboration and innovation at the intersection of health, technology, and sustainability. Its approach is built on the belief that human, animal, plant, and planetary health are deeply interconnected, creating opportunities for cross-sector solutions that can improve health and well-being while supporting a more sustainable future.

Click here for more information

Brussels Airport is a major European hub for the transport of pharmaceutical, biotech, and temperature-sensitive healthcare products. Its specialized infrastructure, dedicated pharma handling processes, and temperature-controlled facilities help ensure the safe and reliable transport of medicines and biological materials while maintaining the required cold chain.

The airport is also increasingly involved in the logistics of personalized medicine and cell and gene therapies. Through initiatives such as the Precision Therapy Logistics Gateway (PTLG), Brussels Airport is exploring how highly sensitive, patient-specific materials such as cell and blood samples can be transported safely, rapidly, and reliably across borders. By combining specialized infrastructure with real-time monitoring and collaboration across the healthcare and logistics sectors, Brussels Airport is helping build the logistics capabilities needed to make advanced and personalized therapies more accessible to patients.

Click here for more information

eyetec is a leading international expert in visual inspection and container closure integrity testing (CCIT), providing a comprehensive range of services to the healthcare, ATMP, and biotech sectors. Its expertise covers the sales, design, maintenance, calibration, and qualification of pharmaceutical manufacturing equipment, supporting companies throughout the equipment lifecycle.

In addition, eyetec provides Qualified Person (QP) services, with a particular focus on ATMP and biotech companies. The company can also support organizations as an interim QA manager or provide expertise for specific, limited assignments, helping clients maintain compliance and quality throughout their operations.

Click here for more information

Fresenius Kabi is a global healthcare company dedicated to providing medicines, technologies, and solutions for critically and chronically ill patients. Its portfolio spans biopharmaceuticals, intravenous medicines and infusion therapy, clinical nutrition, and medical technologies, with a strong focus on improving patient outcomes and making high-quality healthcare more accessible.

In the field of cell and gene therapies, Fresenius Kabi provides scalable and efficient manufacturing solutions that support the entire development lifecycle, from early-stage research through to commercialization. The company develops and manufactures integrated hardware, software, and single-use consumables designed to streamline cell processing workflows, enhance efficiency, and enable consistent, reliable operations.

Fresenius Kabi is also helping advance personalized medicine through innovative cell therapy technologies and decentralized manufacturing initiatives. Projects such as EASYGEN aim to bring CAR-T manufacturing closer to the point of care, while advanced processing platforms such as the Cue Cell Processing System support efficient and standardized cell processing. By enabling more streamlined, scalable, and decentralized approaches to manufacturing, these innovations have the potential to make patient-specific cell and gene therapies faster, safer, and more accessible within hospitals.

Click here for more information

Idevax aims to improve intradermal delivery for preventive, diagnostic, and therapeutic applications, with a focus on cancer vaccines, immunotherapy, and cell- and gene-based therapies.

In cancer, intradermal delivery could support therapeutic vaccines such as BCG, which is used to treat bladder cancer, and Sipuleucel-T, a dendritic cell-based vaccine for castration-resistant prostate cancer.

Idevax is also exploring intradermal delivery for cell-based therapies for autoimmune diseases such as multiple sclerosis (MS). Preserving cell viability, functionality, and phenotype during administration is critical, making gentle delivery with minimal shear stress essential.

Idevax collaborates with the University of Antwerp, Antwerp University Hospital, and Anicells on the intradermal delivery of tolerogenic dendritic cell-based therapy for MS.

Click here for more information

ImmuneSpec is a trusted partner in immunopeptidomics, providing highly sensitive MAPPs (MHC-associated peptide profiling) analyses designed to maximize peptide identification and deliver high-quality, scientifically rigorous results. With a client-focused approach, ImmuneSpec combines advanced analytical capabilities with seamless collaboration and rapid turnaround times, tailoring its solutions to the specific needs of each research program.

By mapping the peptides presented by cells and tissues, ImmuneSpec helps optimize and personalize biotherapeutics by identifying relevant immune targets and supporting the assessment of immunogenicity. These insights can contribute to the development of safer, more targeted, and more effective treatments, supporting the advancement of personalized medicine and improved patient outcomes across a broad range of medical conditions.

Click here for more information

ImmuneWatch is a bioinformatics spin-off of the University of Antwerp and Antwerp University Hospital, dedicated to accelerating the development of T-cell-based diagnostics and therapies. Our mission is to transform complex immune repertoire data into meaningful, actionable insights by accurately annotating T-cell receptors (TCRs) and interpreting their clinical relevance.

By combining advanced bioinformatics, immunology, and data-driven approaches, ImmuneWatch helps researchers and clinicians better understand the adaptive immune response. Our technologies aim to unlock the potential of T-cell receptor data for applications ranging from biomarker discovery and disease monitoring to the development of innovative diagnostics and personalized therapies.

Through our work, we strive to bridge the gap between cutting-edge immune research and clinical application, enabling more informed decisions and supporting the development of next-generation T-cell-based solutions.

Click here for more information

The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing some of the most significant unmet medical needs in oncology, immunology, neuroscience, infectious diseases, and cardiovascular and metabolic diseases. Driven by a culture of innovation, entrepreneurship, and a strong “can-do” mindset, Janssen combines scientific expertise with collaboration to develop transformative therapies that can make a meaningful difference for patients.

A key area of focus is Advanced Therapy Medicinal Products (ATMPs). Since 2017, Johnson & Johnson has invested in the development of CAR-T therapies, with the aim of bringing these highly personalized treatments to more patients. This commitment led to the approval of it’s first CAR-T cell therapy to treat multiple myeloma, or cancer of the bone marrow, in patients for whom other treatments have proven unsuccessful.

To further expand access to these transformative therapies, Janssen is investing significantly in European manufacturing capabilities. A major milestone is the establishment of its first European CAR-T manufacturing center in Ghent, Belgium, in collaboration with Legend Biotech. By strengthening local manufacturing capacity and simplifying production processes, Janssen aims to make personalized cell therapies more scalable, accessible, and available to patients.

This combination of innovation, investment, and collaboration reflects Johnson & Johnson’s commitment to accelerating the development and responsible delivery of next-generation treatments worldwide.

Click here for more information

Miltenyi Biotec is a global provider of innovative products, technologies, and services that empower biomedical research and advance cellular therapies. With more than 30 years of expertise, the company supports scientists and clinicians across the full research and development continuum—from basic and translational research to clinical application and cell manufacturing. Its solutions enable advances in cellular research and cell therapy across fields including immunology, stem cell biology, neuroscience, and cancer.

With more than 4,700 employees across 23 countries, Miltenyi Biotec is dedicated to helping researchers and clinicians accelerate scientific discovery and translate breakthroughs into improved health outcomes.

A key technology in its cell therapy portfolio is the CliniMACS Prodigy®, an automated cell processing platform designed to enable scalable, GMP-compliant manufacturing of cell therapy products. By integrating multiple processing steps on a single device within a closed and standardized process setup, the CliniMACS Prodigy® helps streamline cell therapy manufacturing and support the transition from research to clinical application.

Click here for more information

Orbits provides researchers with a broad range of in vitro cancer models, combined with advanced image analysis software to accelerate cancer research and therapeutic development.

Our services include:
– High-throughput, real-time screening of anti-cancer compounds using models ranging from 2D cell monolayers to advanced 3D co-culture models that closely mimic the tumor microenvironment.
– Flexible, AI-driven image analysis and data management through a cloud-based web application, enabling researchers to process and analyze live-cell images generated in-house.

Whether your focus is drug discovery, therapy screening, personalized medicine, fundamental research, or other areas of cancer research, Orbits provides the models, technology, and expertise you need to accelerate preclinical and clinical development.

Click here for more information

Pharma.Aero is a leading international cross-industry collaboration platform dedicated to advancing logistics in the Life Science and MedTech industries.​ As we celebrate 10 years in 2026, we continue to foster cooperation across the supply chain to address transportation challenges through multimodal solutions encompassing air, sea, and land logistics.

Our organisation brings together almost 100 manufacturers and logistics providers representing all segments of the end-to-end supply chain, including airports, airlines, transporters, freight forwarders, ground-handlers, packaging companies, visibility platforms, and other service providers.

Click here for more information

QIAGEN empowers advancements in cell and gene therapy with precise, reliable solutions for advanced therapies. Our digital PCR technology provides critical support for quality control and quantification, including accurate determination of viral titer, plasmid quality and vector copy number. Trusted by researchers worldwide, our solutions streamline workflows and accelerate biopharmaceutical innovation to bring advanced therapies to market faster.

Click here for more information

Q-People is an expertise agency for quality and compliance within the Life Science industry. Q-People designs, implements and improves quality systems to stimulate product realization. We help companies validate their processes and ensure that procedures and systems guarantee the quality and safety of their products. With the extensive expertise of our team, it is possible to think along with companies at a strategic level. Together with them, we look for the essentials within quality systems, that which is necessary to market products for patients in a qualitative and safe way. Companies can rely on our Q-Academy where we provide training within the Life Cycle of the product. Our collaboration with Co-Valent and Vitalent means that we are very close to the companies in order to respond quickly to their competence needs.

Click here for more information

RegMed XB is a public-private partnership spanning Flanders and the Netherlands, dedicated to developing advanced regenerative therapies that deliver breakthrough benefits for patients while being commercially viable to produce and affordable to society.

The partnership brings together stakeholders across the ‘quadruple helix,’ including national and regional governments, academic and independent research institutions, SMEs and leading life sciences and biotech companies, healthcare organizations, and patient groups. These partners collaborate through four moonshot programmes, each focused on addressing a major non-communicable disease with a significant global healthcare burden: kidney failure, heart failure, Type 1 diabetes, and osteoarthritis.

Click here for more information

Sightera Biosciences, a spin-off of the University of Antwerp in collaboration with Antwerp University Hospital, is advancing oncology and regenerative medicine through the discovery of innovative small molecules. By combining patient-centric models with artificial intelligence, Sightera aims to make drug development faster, more efficient, and more clinically relevant.

At the core of Sightera’s approach is its proprietary SPAR (Structure–Patient–Activity–Relationship) technology, an alternative and complementary approach to conventional small-molecule discovery. SPAR integrates chemical structures with patient-centric models to identify and develop more effective, relevant therapies from the outset.

By embedding patient relevance into the earliest stages of drug discovery, Sightera seeks to overcome limitations of traditional development and accelerate the path toward small-molecule therapies with a stronger potential for clinical impact.

Click here for more information

Sure Laboratories is an independent, well experienced microbiological laboratory based in the southern part of the Netherlands near to the Antwerp region. We are dedicated to microbiological analyses such bioburden, bacterial endotoxins and sterility testing (working on rapid methods), clean room monitoring and virus-reduction testing to support our customers in the Life Science Industry (Pharmacy, Regenerative Medicines and ATMP-industry). It is our mission to accelerate your R&D and QC processes, using short communication lines with a high level of microbiological knowledge. All quality tests are executed according to an ISO 13485:2016 quality system and the EU-GMP principles.Sure Laboratories is an independent, well experienced microbiological laboratory based in the southern part of the Netherlands near to the Antwerp region. We are dedicated to microbiological analyses such bioburden, bacterial endotoxins and sterility testing (working on rapid methods), clean room monitoring and virus-reduction testing to support our customers in the Life Science Industry (Pharmacy, Regenerative Medicines and ATMP-industry). It is our mission to accelerate your R&D and QC processes, using short communication lines with a high level of microbiological knowledge. All quality tests are executed according to an ISO 13485:2016 quality system and the EU-GMP principles.

Click here for more information

Thermo Fisher Scientific connects you with the solutions, expertise, and support you need to reach your next milestone and advance your cell and gene therapy journey. From discovery through clinical research and commercial manufacturing, our high-quality materials, services, and support help accelerate your workflow and keep your programs moving forward. With technical expertise, regulatory guidance, and customizable or off-the-shelf solutions, we help you overcome challenges, streamline processes, and advance your cell and gene therapies toward success.

Click here for more information

TRU is the leading expert in professional cleanroom and equipment cleaning. As specialized and experienced cleanroom cleaners, we clean your controlled production environment according to fixed procedures. The result is a spotless cleanroom that meets strict industry standards.

Click here for more information

Vetoquinol is a leading global animal health company driven by its mission to enrich the lives of people through dedication to animal health and welfare. We have the ambition to be a pioneer company for ATMPs on this market and are looking for partnerships on technologies developed for animal or human health.

Want to know more about our animal health, assess the potential of your technology, and understand the market access? Contact us!

Click here for more information

ViTalent is the Flemish training center for the Life Sciences ecosystem. Our mission is to strengthen and anchor the Life Sciences sector in Flanders through our training portfolio and state-of-the-art jobsimulator. We provide job-oriented trainings for both professionals and job seekers and collaborate with educational partners to supplement courses with practical Life Sciences experience.
In our training facility in Niel we built a simulated GMP production site with labs, a procesunit, a formulation and packaging department and a full cleanroom with all the equipment needed to provide excellent trainings for all the different profiles that contribute to the wellbeing of your patients.

Click here for more information